Literature DB >> 21290054

Correlation of p16(INK4A) expression and HPV copy number with cellular FTIR spectroscopic signatures of cervical cancer cells.

Kamila M Ostrowska1, Amaya Garcia, Aidan D Meade, Alison Malkin, Ifeoluwapo Okewumi, John J O'Leary, Cara Martin, Hugh J Byrne, Fiona M Lyng.   

Abstract

Cervical cancer, a potentially preventable disease, has its main aetiology in infection by high risk human papillomavirus (HR-HPV). Approaches to improving cervical cancer screening and diagnostic methodologies include molecular biological analysis, targeting of biomarker proteins, but also exploration and implementation of new techniques such as vibrational spectroscopy. This study correlates the biomarker protein p16(INK4A) expression levels dependent on HPV copy number with the infrared absorption spectral signatures of the cervical cancer cell lines, HPV negative C33A, HPV-16 positive SiHa and CaSki and HPV-18 positive HeLa. Confocal fluorescence microscopy demonstrated that p16(INK4A) is expressed in all investigated cell lines in both nuclear and cytoplasmic regions, although predominantly in the cytoplasm. Flow cytometry was used to quantify the p16(INK4A) expression levels and demonstrated a correlation, albeit nonlinear, between the reported number of integrated HPV copies and p16(INK4A) expression levels. CaSki cells were found to have the highest level of expression, HeLa intermediate levels, and SiHa and C33A the lowest levels. FTIR spectra revealed differences in nucleic acid, lipid and protein signatures between the cell lines with varying HPV copy number. Peak intensities exhibited increasing tendency in nucleic acid levels and decreasing tendency in lipid levels with increasing HPV copy number, and although they were found to be nonlinearly correlated with the HPV copy number, their dependence on p16(INK4A) levels was found to be close to linear. Principal Component Analysis (PCA) of the infrared absorption spectra revealed differences between nuclear and cytoplasmic spectroscopic signatures for all cell lines, and furthermore clearly differentiated the groups of spectra representing each cell line. Finally, Partial Least Squares (PLS) analysis was employed to construct a model which can predict the p16(INK4A) expression level based on a spectral fingerprint of a cell line, demonstrating the diagnostic potential of spectroscopic techniques. © The Royal Society of Chemistry 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21290054     DOI: 10.1039/c0an00910e

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  7 in total

1.  Infrared spectroscopy and microscopy in cancer research and diagnosis.

Authors:  Giuseppe Bellisola; Claudio Sorio
Journal:  Am J Cancer Res       Date:  2011-11-22       Impact factor: 6.166

2.  Combining Pharmacokinetics and Vibrational Spectroscopy: MCR-ALS Hard-and-Soft Modelling of Drug Uptake In Vitro Using Tailored Kinetic Constraints.

Authors:  David Pérez-Guaita; Guillermo Quintás; Zeineb Farhane; Romá Tauler; Hugh J Byrne
Journal:  Cells       Date:  2022-05-05       Impact factor: 7.666

3.  Near-infrared Raman Microspectroscopy Detects High-risk Human Papillomaviruses.

Authors:  Elizabeth Vargis; Yi-Wei Tang; Dineo Khabele; Anita Mahadevan-Jansen
Journal:  Transl Oncol       Date:  2012-06-01       Impact factor: 4.243

4.  Simultaneous Detection and Viral DNA Load Quantification of Different Human Papillomavirus Types in Clinical Specimens by the High Analytical Droplet Digital PCR Method.

Authors:  John Charles Rotondo; Lucia Oton-Gonzalez; Chiara Mazziotta; Carmen Lanzillotti; Maria Rosa Iaquinta; Mauro Tognon; Fernanda Martini
Journal:  Front Microbiol       Date:  2020-11-19       Impact factor: 5.640

5.  One step DNA amplification of mammalian cells in picoliter microwell arrays.

Authors:  Wenwen Liu; Zhao Li; Yuanjie Liu; Qingquan Wei; Yong Liu; Lufeng Ren; Chenyu Wang; Yude Yu
Journal:  RSC Adv       Date:  2019-01-21       Impact factor: 4.036

6.  Metadata analysis to explore hub of the hub-genes highlighting their functions, pathways and regulators for cervical cancer diagnosis and therapies.

Authors:  Md Selim Reza; Md Alim Hossen; Md Harun-Or-Roshid; Mst Ayesha Siddika; Md Hadiul Kabir; Md Nurul Haque Mollah
Journal:  Discov Oncol       Date:  2022-08-22

7.  The HPV16E7 Affibody as a Novel Potential Therapeutic Agent for Treating Cervical Cancer Is Likely Internalized through Dynamin and Caveolin-1 Dependent Endocytosis.

Authors:  Qingyuan Zhang; Hua Zhu; Zhouying Cui; Yuxiao Li; Jiaying Zhuo; Jingwei Ye; Zhihui Zhang; Zheng Lian; Qianqian Du; Kong-Nan Zhao; Lifang Zhang; Pengfei Jiang
Journal:  Biomolecules       Date:  2022-08-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.